• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与β3肾上腺素能受体不同的非典型β肾上腺素能受体介导CGP 12177和氰吲哚洛尔对去大脑大鼠的正性变时作用。

Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors.

作者信息

Malinowska B, Schlicker E

机构信息

Zakład Farmakodynamiki, Akademia Medyczna, Białystok, Poland.

出版信息

Br J Pharmacol. 1996 Mar;117(5):943-9. doi: 10.1111/j.1476-5381.1996.tb15285.x.

DOI:10.1111/j.1476-5381.1996.tb15285.x
PMID:8851515
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1909427/
Abstract
  1. The influence of beta 1-, beta 2-, and beta 3-adrenoceptor agonists and of CGP 12177 and cyanopindolol on heart rate and diastolic blood pressure was studied in the pithed rat. 2. The beta 1-adrenoceptor agonist, prenalterol, increased heart rate and the beta 2-adrenoceptor agonist, fenoterol, caused a fall in blood pressure. The effect of prenalterol was antagonized by the beta 1-adrenoceptor antagonist, CGP 20712 0.1 mumol kg-1 and the action of fenoterol was attenuated by the beta 2-adrenoceptor antagonist, ICI 118551 0.1 mumol kg-1. Both effects were markedly diminished by the non-selective beta-adrenoceptor antagonist, bupranolol 0.1 mumol kg-1. 3. The non-selective beta-adrenoceptor agonist, isoprenaline, three beta 3-agonists as well as CGP 12177 and cyanopindolol elicited a positive chronotropic effect, exhibiting the following pED delta 60 values (negative log values of the doses increasing heart rate by 60 beats min-1): isoprenaline 10.4, CGP 12177 8.3, cyanopindolol 7.2, BRL 37344 6.9, ZD 2079 5.2 and CL 316243 < 5. 4. CGP 20712 0.1 mumol kg-1, given together with ICI 118551 0.1 mumol kg-1, markedly attenuated the positive chronotropic effect of isoprenaline, BRL 37344, ZD 2079 and CL 316243 without affecting the increase in heart rate produced by CGP 12177 and cyanopindolol. 5. The positive chronotropic effect of CGP 12177 and cyanopindolol was attenuated by CGP 20712, 1 and 10 mumol kg-1 and bupranolol, 10 mumol kg-1 but was not affected by ICI 118551, 10 mumol kg-1. The effect of CGP 12177 was also not changed by BRL 37344 1 mumol kg-1, ZD 2079 10 mumol kg-1, CL 316243 10 mumol kg-1, the alpha 1-adrenoceptor antagonist, prazosin 1 mumol kg-1 and the 5-hydroxytryptamine 5-HT2A receptor antagonist, ketanserin 3 mumol kg-1. 6. CGP 12177 0.002 mumol kg-1 and cyanopindolol 0.003 mumol kg-1 shifted to the right the dose-response curve of prenalterol for its positive chronotropic effect. The -log values of the doses causing a twofold shift to the right were 9.6 and 9.5, respectively. 7. Isoprenaline 0.00001-0.001 mumol kg-1, BRL 37344 0.01-1 mumol kg-1 and CGP 12177 0.1 mumol kg-1 caused a fall in diastolic blood pressure which was markedly attenuated by combined administration of CGP 20712 and ICI 118551, 0.1 mumol kg-1 each. 8. CGP 12177 0.01 and 0.1 mumol kg-1 and cyanopindolol 1 mumol kg-1 elicited an increase in diastolic blood pressure. CGP 20712, ICI 118551, bupranolol and, in the case of CGP 12177, also BRL 37344, ZD 2079, CL 316243, prazosin and ketanserin did not influence this effect. 9. In conclusion, the positive chronotropic effect of CGP 12177 and cyanopindolol is not mediated via beta 1-, beta 2-, beta 3-, alpha 1-adrenoceptors or 5-HT2A receptors. This effect may involve atypical beta-adrenoceptors, similar or identical to those described by Kaumann (1989) in isolated heart preparations.
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a062/1909427/f31d8218cec1/brjpharm00094-0184-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a062/1909427/f31d8218cec1/brjpharm00094-0184-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a062/1909427/f31d8218cec1/brjpharm00094-0184-a.jpg
摘要
  1. 在脊髓横断大鼠中研究了β1、β2和β3肾上腺素能受体激动剂以及CGP 12177和氰吲哚洛尔对心率和舒张压的影响。2. β1肾上腺素能受体激动剂普瑞特罗可增加心率,β2肾上腺素能受体激动剂非诺特罗可使血压下降。普瑞特罗的作用可被β1肾上腺素能受体拮抗剂CGP 20712(0.1 μmol/kg)拮抗,非诺特罗的作用可被β2肾上腺素能受体拮抗剂ICI 118551(0.1 μmol/kg)减弱。两种作用均被非选择性β肾上腺素能受体拮抗剂布普洛尔(0.1 μmol/kg)显著减弱。3. 非选择性β肾上腺素能受体激动剂异丙肾上腺素、三种β3激动剂以及CGP 12177和氰吲哚洛尔均产生正性变时作用,其pEDδ60值(使心率增加60次/分钟的剂量的负对数值)如下:异丙肾上腺素10.4、CGP 12177 8.3、氰吲哚洛尔7.2、BRL 373,44 6.9、ZD 2079 5.2和CL 316243<5。4. 将CGP 20712(0.1 μmol/kg)与ICI 118551(0.1 μmol/kg)合用时,可显著减弱异丙肾上腺素、BRL 37344、ZD 2079和CL 316243的正性变时作用,而不影响CGP 12177和氰吲哚洛尔引起的心率增加。5. CGP 12177和氰吲哚洛尔的正性变时作用可被CGP 20712(1和10 μmol/kg)和布普洛尔(10 μmol/kg)减弱,但不受ICI 118551(10 μmol/kg)影响。CGP 12177的作用也不受BRL 37344(1 μmol/kg)、ZD 2079(10 μmol/kg)、CL 316,243(10 μmol/kg)、α1肾上腺素能受体拮抗剂哌唑嗪(1 μmol/kg)和5-羟色胺5-HT2A受体拮抗剂酮色林(3 μmol/kg)的影响。6. CGP 12177(0.002 μmol/kg)和氰吲哚洛尔(0.003 μmol/kg)使普瑞特罗正性变时作用的剂量-反应曲线右移。使曲线右移两倍的剂量的负对数值分别为9.6和9.5。7. 异丙肾上腺素(0.00001 - 0.001 μmol/kg)、BRL 37344(0.01 - 1 μmol/kg)和CGP 121,77(0.1 μmol/kg)可使舒张压下降,联合给予CGP 20712和ICI 118551(各0.1 μmol/kg)可显著减弱此作用。8. CGP 12177(0.01和0.1 μmol/kg)和氰吲哚洛尔(1 μmol/kg)可使舒张压升高。CGP 20712、ICI 118551、布普洛尔以及对于CGP 12177而言,BRL 37344、ZD 2079、CL 316243、哌唑嗪和酮色林均不影响此作用。9. 总之,CGP 12177和氰吲哚洛尔的正性变时作用不是通过β1、β2、β3、α1肾上腺素能受体或5-HT2A受体介导的。此作用可能涉及非典型β肾上腺素能受体,类似于或等同于考曼(1989年)在离体心脏标本中描述的那些受体。

相似文献

1
Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors.与β3肾上腺素能受体不同的非典型β肾上腺素能受体介导CGP 12177和氰吲哚洛尔对去大脑大鼠的正性变时作用。
Br J Pharmacol. 1996 Mar;117(5):943-9. doi: 10.1111/j.1476-5381.1996.tb15285.x.
2
Further evidence for differences between cardiac atypical beta-adrenoceptors and brown adipose tissue beta3-adrenoceptors in the pithed rat.在脊髓横断大鼠中,心脏非典型β-肾上腺素能受体与棕色脂肪组织β3-肾上腺素能受体之间差异的进一步证据。
Br J Pharmacol. 1997 Dec;122(7):1307-14. doi: 10.1038/sj.bjp.0701516.
3
Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.大鼠心脏第三种β-肾上腺素能受体与结肠β3-肾上腺素能受体之间的差异
Br J Pharmacol. 1996 Aug;118(8):2085-98. doi: 10.1111/j.1476-5381.1996.tb15648.x.
4
Beta 1-, beta 2- and atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta.β1、β2和非典型β-肾上腺素能受体介导的大鼠离体主动脉舒张
Br J Pharmacol. 2000 Feb;129(4):637-44. doi: 10.1038/sj.bjp.0703091.
5
Atypical responses of rat ileum to pindolol, cyanopindolol and iodocyanopindolol.大鼠回肠对吲哚洛尔、氰基吲哚洛尔和碘氰基吲哚洛尔的非典型反应。
Br J Pharmacol. 1996 Feb;117(4):712-6. doi: 10.1111/j.1476-5381.1996.tb15248.x.
6
Atypical cardiostimulant beta-adrenoceptor in the rat heart: stereoselective antagonism by bupranolol but lack of effect by some bupranolol analogues.大鼠心脏中的非典型心脏兴奋剂β-肾上腺素能受体:布普洛尔的立体选择性拮抗作用,但某些布普洛尔类似物无此效应。
Br J Pharmacol. 2003 Aug;139(8):1548-54. doi: 10.1038/sj.bjp.0705390.
7
Recruitment of functionally active heart beta2-adrenoceptors in the initial phase of endotoxic shock in pithed rats.去大脑大鼠内毒素休克初始阶段功能性活性心脏β2 - 肾上腺素能受体的募集
Shock. 2006 Nov;26(5):510-5. doi: 10.1097/01.shk.0000228794.95302.c3.
8
Atypical beta-adrenoceptors, different from beta 3-adrenoceptors and probably from the low-affinity state of beta 1-adrenoceptors, relax the rat isolated mesenteric artery.非典型β-肾上腺素能受体不同于β3-肾上腺素能受体,可能也不同于β1-肾上腺素能受体的低亲和力状态,它能使大鼠离体肠系膜动脉舒张。
Br J Pharmacol. 2003 Sep;140(1):3-12. doi: 10.1038/sj.bjp.0705421. Epub 2003 Aug 4.
9
ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta.CGP 12177A及其他β-肾上腺素能受体配体的α1-肾上腺素能受体拮抗剂特性:大鼠主动脉中不存在β(3)-或非典型β-肾上腺素能受体的证据
Br J Pharmacol. 2004 Jun;142(4):781-7. doi: 10.1038/sj.bjp.0705840.
10
Positive inotropic and lusitropic effects mediated via the low-affinity state of beta1-adrenoceptors in pithed rats.在脊髓横断大鼠中,通过β1 - 肾上腺素能受体的低亲和力状态介导的正性肌力和变时性作用。
Br J Pharmacol. 2005 Nov;146(5):760-8. doi: 10.1038/sj.bjp.0706382.

引用本文的文献

1
Adrenoceptors: Receptors, Ligands and Their Clinical Uses, Molecular Pharmacology and Assays.肾上腺素能受体:受体、配体及其临床用途,分子药理学和检测。
Handb Exp Pharmacol. 2024;285:55-145. doi: 10.1007/164_2024_713.
2
Cardiac β -adrenoceptors-A role in human pathophysiology?心脏β-肾上腺素能受体——在人类病理生理学中的作用?
Br J Pharmacol. 2019 Jul;176(14):2482-2495. doi: 10.1111/bph.14635. Epub 2019 Apr 22.
3
MH-3: evidence for non-competitive antagonism towards the low-affinity site of β1-adrenoceptors.MH - 3:对β1 - 肾上腺素能受体低亲和力位点存在非竞争性拮抗作用的证据。

本文引用的文献

1
Identification of endothelial H1, vascular H2 and cardiac presynaptic H3 receptors in the pithed rat.去大脑大鼠中内皮H1、血管H2和心脏突触前H3受体的鉴定。
Naunyn Schmiedebergs Arch Pharmacol. 1993 Jan;347(1):55-60. doi: 10.1007/BF00168772.
2
Beta 3 and atypical beta-adrenoceptors.β3及非典型β-肾上腺素能受体
Med Res Rev. 1993 Nov;13(6):663-729. doi: 10.1002/med.2610130604.
3
Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.β-3肾上腺素能受体介导的犬皮肤血流量增加。
Naunyn Schmiedebergs Arch Pharmacol. 2014 Aug;387(8):743-52. doi: 10.1007/s00210-014-0983-3. Epub 2014 May 3.
4
Identification of key residues in transmembrane 4 responsible for the secondary, low-affinity conformation of the human β1-adrenoceptor.鉴定跨膜 4 中负责人类β1-肾上腺素能受体次要、低亲和力构象的关键残基。
Mol Pharmacol. 2014 May;85(5):811-29. doi: 10.1124/mol.114.091587. Epub 2014 Mar 7.
5
β-Adrenergic Receptor-Stimulated Cardiac Myocyte Apoptosis: Role of β1 Integrins.β-肾上腺素能受体刺激的心肌细胞凋亡:β1整合素的作用
J Signal Transduct. 2011;2011:179057. doi: 10.1155/2011/179057. Epub 2011 May 24.
6
The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from beta3-adrenoceptor agonists.肥胖症药物的发现、瘦素的代谢作用及可变受体药理学:β3-肾上腺素能受体激动剂的视角
Naunyn Schmiedebergs Arch Pharmacol. 2008 Aug;378(2):225-40. doi: 10.1007/s00210-008-0271-1. Epub 2008 Jul 9.
7
A study of antagonist affinities for the human histamine H2 receptor.一项关于人类组胺H2受体拮抗剂亲和力的研究。
Br J Pharmacol. 2008 Mar;153(5):1011-21. doi: 10.1038/sj.bjp.0707644. Epub 2007 Dec 24.
8
Positive inotropic and lusitropic effects mediated via the low-affinity state of beta1-adrenoceptors in pithed rats.在脊髓横断大鼠中,通过β1 - 肾上腺素能受体的低亲和力状态介导的正性肌力和变时性作用。
Br J Pharmacol. 2005 Nov;146(5):760-8. doi: 10.1038/sj.bjp.0706382.
9
Direct demonstration of beta1- and evidence against beta2- and beta3-adrenoceptors, in smooth muscle cells of rat small mesenteric arteries.在大鼠小肠系膜动脉平滑肌细胞中直接证实β1-肾上腺素能受体,并排除β2-和β3-肾上腺素能受体。
Br J Pharmacol. 2005 Nov;146(5):679-91. doi: 10.1038/sj.bjp.0706369.
10
ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta.CGP 12177A及其他β-肾上腺素能受体配体的α1-肾上腺素能受体拮抗剂特性:大鼠主动脉中不存在β(3)-或非典型β-肾上腺素能受体的证据
Br J Pharmacol. 2004 Jun;142(4):781-7. doi: 10.1038/sj.bjp.0705840.
J Pharmacol Exp Ther. 1994 Mar;268(3):1444-51.
4
Peripheral vascular effects of beta-3 adrenergic receptor stimulation in conscious dogs.
J Pharmacol Exp Ther. 1994 Jan;268(1):466-73.
5
Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.决定β3-肾上腺素能受体中选择性信号转导的结构和构象特征。
Mol Pharmacol. 1993 Dec;44(6):1094-104.
6
The beta-adrenoceptor selectivity profile of BRL 37344 in the pithed rat.BRL 37344在脊髓毁损大鼠中的β-肾上腺素受体选择性概况。
J Auton Pharmacol. 1994 Oct;14(5):337-44. doi: 10.1111/j.1474-8673.1994.tb00614.x.
7
Stimulant and blocking effects of optical isomers of pindolol on the sinoatrial node and trachea of guinea pig. Role of beta-adrenoceptor subtypes in the dissociation between blockade and stimulation.吲哚洛尔光学异构体对豚鼠窦房结和气管的兴奋及阻断作用。β-肾上腺素能受体亚型在阻断与兴奋解离中的作用。
Naunyn Schmiedebergs Arch Pharmacol. 1984 Sep;327(2):159-75. doi: 10.1007/BF00500912.
8
Is there a third heart beta-adrenoceptor?是否存在第三种心脏β-肾上腺素能受体?
Trends Pharmacol Sci. 1989 Aug;10(8):316-20. doi: 10.1016/0165-6147(89)90065-5.
9
Molecular characterization of the human beta 3-adrenergic receptor.人β3 -肾上腺素能受体的分子特征
Science. 1989 Sep 8;245(4922):1118-21. doi: 10.1126/science.2570461.
10
Molecular cloning and expression of the rat beta 3-adrenergic receptor.
Mol Pharmacol. 1991 Dec;40(6):895-9.